468 related articles for article (PubMed ID: 28324303)
1. Subtypes of Parkinson's Disease: What Do They Tell Us About Disease Progression?
Fereshtehnejad SM; Postuma RB
Curr Neurol Neurosci Rep; 2017 Apr; 17(4):34. PubMed ID: 28324303
[TBL] [Abstract][Full Text] [Related]
2. Clinical criteria for subtyping Parkinson's disease: biomarkers and longitudinal progression.
Fereshtehnejad SM; Zeighami Y; Dagher A; Postuma RB
Brain; 2017 Jul; 140(7):1959-1976. PubMed ID: 28549077
[TBL] [Abstract][Full Text] [Related]
3. Subtypes of Parkinson's disease: state of the field and future directions.
Marras C
Curr Opin Neurol; 2015 Aug; 28(4):382-6. PubMed ID: 26110797
[TBL] [Abstract][Full Text] [Related]
4. Nonmotor Subtyping in Parkinson's Disease.
Sauerbier A; Rosa-Grilo M; Qamar MA; Chaudhuri KR
Int Rev Neurobiol; 2017; 133():447-478. PubMed ID: 28802928
[TBL] [Abstract][Full Text] [Related]
5. New Clinical Subtypes of Parkinson Disease and Their Longitudinal Progression: A Prospective Cohort Comparison With Other Phenotypes.
Fereshtehnejad SM; Romenets SR; Anang JB; Latreille V; Gagnon JF; Postuma RB
JAMA Neurol; 2015 Aug; 72(8):863-73. PubMed ID: 26076039
[TBL] [Abstract][Full Text] [Related]
6. Nonmotor features of Parkinson's disease subtypes.
Marras C; Chaudhuri KR
Mov Disord; 2016 Aug; 31(8):1095-102. PubMed ID: 26861861
[TBL] [Abstract][Full Text] [Related]
7. Blood biomarkers with Parkinson's disease clusters and prognosis: The oxford discovery cohort.
Lawton M; Baig F; Toulson G; Morovat A; Evetts SG; Ben-Shlomo Y; Hu MT
Mov Disord; 2020 Feb; 35(2):279-287. PubMed ID: 31693246
[TBL] [Abstract][Full Text] [Related]
8. Advanced Parkinson's or "complex phase" Parkinson's disease? Re-evaluation is needed.
Titova N; Martinez-Martin P; Katunina E; Chaudhuri KR
J Neural Transm (Vienna); 2017 Dec; 124(12):1529-1537. PubMed ID: 29116411
[TBL] [Abstract][Full Text] [Related]
9. Therapy of Parkinson's Disease Subtypes.
Marras C; Chaudhuri KR; Titova N; Mestre TA
Neurotherapeutics; 2020 Oct; 17(4):1366-1377. PubMed ID: 32749651
[TBL] [Abstract][Full Text] [Related]
10. Parkinson's disease--the continuing search for biomarkers.
Breen DP; Michell AW; Barker RA
Clin Chem Lab Med; 2011 Mar; 49(3):393-401. PubMed ID: 21288170
[TBL] [Abstract][Full Text] [Related]
11. Nonmotor Parkinson's and Future Directions.
Titova N; Chaudhuri KR
Int Rev Neurobiol; 2017; 134():1493-1505. PubMed ID: 28805581
[TBL] [Abstract][Full Text] [Related]
12. Data-Driven Subtyping of Parkinson's Disease Using Longitudinal Clinical Records: A Cohort Study.
Zhang X; Chou J; Liang J; Xiao C; Zhao Y; Sarva H; Henchcliffe C; Wang F
Sci Rep; 2019 Jan; 9(1):797. PubMed ID: 30692568
[TBL] [Abstract][Full Text] [Related]
13. Presentations of nonmotor symptoms by sex and onset age in people with Parkinson's disease.
Lee J; Sohn YH; Chung SJ; Kim E; Kim Y
Int J Nurs Pract; 2024 Apr; 30(2):e13177. PubMed ID: 37394896
[TBL] [Abstract][Full Text] [Related]
14. Body side and predominant motor features at the onset of Parkinson's disease are linked to motor and nonmotor progression.
Baumann CR; Held U; Valko PO; Wienecke M; Waldvogel D
Mov Disord; 2014 Feb; 29(2):207-13. PubMed ID: 24105646
[TBL] [Abstract][Full Text] [Related]
15. The Pathophysiological Correlates of Parkinson's Disease Clinical Subtypes.
Belvisi D; Fabbrini A; De Bartolo MI; Costanzo M; Manzo N; Fabbrini G; Defazio G; Conte A; Berardelli A
Mov Disord; 2021 Feb; 36(2):370-379. PubMed ID: 33037859
[TBL] [Abstract][Full Text] [Related]
16. Biomarkers of Parkinson's Disease: An Introduction.
Titova N; Qamar MA; Chaudhuri KR
Int Rev Neurobiol; 2017; 132():183-196. PubMed ID: 28554407
[TBL] [Abstract][Full Text] [Related]
17. Parkinson's Disease Subtypes: Critical Appraisal and Recommendations.
Mestre TA; Fereshtehnejad SM; Berg D; Bohnen NI; Dujardin K; Erro R; Espay AJ; Halliday G; van Hilten JJ; Hu MT; Jeon B; Klein C; Leentjens AFG; Marinus J; Mollenhauer B; Postuma R; Rajalingam R; Rodríguez-Violante M; Simuni T; Surmeier DJ; Weintraub D; McDermott MP; Lawton M; Marras C
J Parkinsons Dis; 2021; 11(2):395-404. PubMed ID: 33682731
[TBL] [Abstract][Full Text] [Related]
18. Transitioning from Subtyping to Precision Medicine in Parkinson's Disease: A Purpose-Driven Approach.
Marras C; Fereshtehnejad SM; Berg D; Bohnen NI; Dujardin K; Erro R; Espay AJ; Halliday G; Van Hilten JJ; Hu MT; Jeon B; Klein C; Leentjens AFG; Mollenhauer B; Postuma RB; Rodríguez-Violante M; Simuni T; Weintraub D; Lawton M; Mestre TA
Mov Disord; 2024 Mar; 39(3):462-471. PubMed ID: 38243775
[TBL] [Abstract][Full Text] [Related]
19. Characterization of Parkinson's Disease Subtypes and Related Attributes.
Shakya S; Prevett J; Hu X; Xiao R
Front Neurol; 2022; 13():810038. PubMed ID: 35677337
[TBL] [Abstract][Full Text] [Related]
20. Advances in the Clinical Differential Diagnosis of Parkinson's Disease.
Schreglmann SR; Bhatia KP; Stamelou M
Int Rev Neurobiol; 2017; 132():79-127. PubMed ID: 28554422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
